EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Operating cash flow, 2025
- $1.6B
- YoY, 2025
- +194.2%
- 5-year CAGR
- +8.6%
- 10-year CAGR
- +11.2%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $1.6B | +194.2% |
| 2024 | $542M | −39.5% |
| 2023 | $896M | −26.5% |
| 2022 | $1.2B | −29.7% |
| 2021 | $1.7B | +64.3% |
| 2020 | $1.1B | −10.9% |
| 2019 | $1.2B | +27.6% |
| 2018 | $927M | −7.4% |
| 2017 | $1.0B | +42.1% |
| 2016 | $704M | +28.1% |
| 2015 | $550M | −46.2% |
| 2014 | $1.0B | +116.3% |
| 2013 | $473M | +30.5% |
| 2012 | $362M | +17.5% |
| 2011 | $308M | +22.6% |
| 2010 | $251M | +52.1% |
| 2009 | $165M | +7.9% |
| 2008 | $153M | — |